JP Morgan Chase’s State Street SPDR S&P Health Care Services ETF XHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.61M Buy
50,544
+48,544
+2,427% +$5.51M ﹤0.01% 3181
2026
Q1
$197K Buy
+2,000
New +$213K ﹤0.01% 5479
2024
Q4
Sell
-1,000
Closed -$96.9K 7767
2024
Q3
$96.9K Buy
1,000
+879
+726% +$84K ﹤0.01% 5713
2024
Q2
$10.9K Buy
+121
New +$10.9K ﹤0.01% 6248
2019
Q3
Sell
-3,300
Closed -$217K 5987
2019
Q2
$217K Sell
3,300
-12,076
-79% -$777K ﹤0.01% 4635
2019
Q1
$992K Buy
15,376
+3,244
+27% +$218K ﹤0.01% 3811
2018
Q4
$759K Buy
12,132
+8,832
+268% +$630K ﹤0.01% 3905
2018
Q3
$252K Hold
3,300
﹤0.01% 4596
2018
Q2
$229K Hold
3,300
﹤0.01% 4507
2018
Q1
$208K Buy
+3,300
New +$213K ﹤0.01% 4357
2017
Q3
Sell
-137
Closed -$9K 5213
2017
Q2
$9K Sell
137
-128
-48% -$7.73K ﹤0.01% 4680
2017
Q1
$15K Buy
+265
New +$15K ﹤0.01% 4751

Other funds holding XHS

JP Morgan Chase's XHS Position: Q2 2026 in Review

JP Morgan Chase increased its State Street SPDR S&P Health Care Services ETF (XHS) stake by 2,427% in Q2 2026, buying an estimated $5.51M and bringing the position to 50,544 shares worth $6.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3181.

JP Morgan Chase first reported a position in XHS in Q1 2017 and has held it in 12 quarters since. 69 funds tracked by Wall St. Rank hold XHS as of Q2 2026.

  • JP Morgan Chase held 50,544 shares of State Street SPDR S&P Health Care Services ETF worth $6.61M as of Q2 2026.
  • JP Morgan Chase bought 48,544 State Street SPDR S&P Health Care Services ETF shares in Q2 2026, an estimated $5.51M.
  • State Street SPDR S&P Health Care Services ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3181 holding.
  • JP Morgan Chase first reported a position in State Street SPDR S&P Health Care Services ETF in Q1 2017 and has held it in 12 quarters since.
  • 69 funds tracked by Wall St. Rank held State Street SPDR S&P Health Care Services ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.